Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT05294367
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Magnesium Chloride-based Lotion — DRUG
    Given topically
  • Quality-of-Life Assessment — OTHER
    Ancillary studies
  • Special Diet Therapy — BEHAVIORAL
    Consume magnesium rich foods

Study Details

This early phase I trial investigates the effect of dietary and topical magnesium replacement on magnesium blood levels in patients with lymphoma. Magnesium is an element in the body that is important to cell health. The body cannot make magnesium and it typically comes from the food we eat. In patients who are ill, magnesium is often replaced intravenously (IV) through a vein or by mouth. This study may help researchers find out if being on a magnesium rich diet and using a magnesium lotion on the skin helps to keep magnesium blood levels in an ideal range. This study also investigates side effects and quality of life when receiving different forms of magnesium.

Key Dates

Start date
Apr 15, 2022
Status verified
Mar 2026
Primary completion
Apr 1, 2027
Completion
Apr 1, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT

Arms

  • Experimental: Cycle 1
    Participants consume magnesium rich foods PO daily for 28 days.
  • Experimental: Cycle 2, Arm I
    Participants continue consuming magnesium rich foods PO daily and apply Ancient Minerals Magnesium Lotion topically daily for 28 days.
  • Experimental: Cycle 2, Arm II
    Participants continue consuming magnesium rich foods PO daily for 28 days.

Primary Outcome Measure

Improvement in serum magnesium levels [ Time Frame: Baseline up to 2 cycles (56 days) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trial Referral Office
[email protected]
855-776-0015
Thomas E. Witzig, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies